MYC-regulated Mevalonate Metabolism Maintains Brain Tumor Initiating Cells

Metabolic dysregulation drives tumor initiation in a subset of glioblastomas harboring isocitrate dehydrogenase (IDH) mutations, but metabolic alterations in glioblastomas with wildtype IDH are poorly understood. MYC promotes metabolic reprogramming in cancer, but targeting MYC has proven notoriousl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Wang, Xiuxing, Huang, Zhi, Wu, Qiulian, Prager, Briana C., Mack, Stephen C., Yang, Kailin, Kim, Leo J.Y., Gimple, Ryan C., Shi, Yu, Lai, Sisi, Xie, Qi, Miller, Tyler E., Hubert, Christopher G., Song, Anne, Dong, Zhen, Zhou, Wenchao, Fang, Xiaoguang, Zhu, Zhe, Mahadev, Vaidehi, Bao, Shideng, Rich, Jeremy N.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5600855/
https://ncbi.nlm.nih.gov/pubmed/28729418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-17-0114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados